Literature DB >> 9017527

Subjective complaints versus actual cognitive deficits in predominantly symptomatic HIV-1 seropositive individuals.

L H Moore1, W G van Gorp, C H Hinkin, M J Stern, T Swales, P Satz.   

Abstract

The relationship of self-reported cognitive, motor, and affective complaints to actual neuropsychological functioning was explored in a cohort of predominantly symptomatic HIV-1 seropositive individuals. Ninety-two symptomatic HIV-1 infected subjects were questioned about complaints common in HIV infection and were assessed with a comprehensive neuropsychological test battery. No relationship was found between subjective complaints and cognitive functioning, yet a significant relationship was found between self-reported difficulties and formal measures of affect and mood. Failure to show a relationship between self-reported cognitive status and actual neuropsychological functioning in this cohort suggests that complaints of cognitive decline may be attributable to emotional factors.

Entities:  

Mesh:

Year:  1997        PMID: 9017527     DOI: 10.1176/jnp.9.1.37

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  12 in total

Review 1.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

2.  Subjective cognitive complaints and longitudinal changes in memory and brain function.

Authors:  Timothy J Hohman; Lori L Beason-Held; Melissa Lamar; Susan M Resnick
Journal:  Neuropsychology       Date:  2011-01       Impact factor: 3.295

3.  Human immunodeficiency virus and depression in primary care: a clinical review.

Authors:  Tiziano Colibazzi; Teresa T Hsu; William S Gilmer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance.

Authors:  April D Thames; Brian W Becker; Thomas D Marcotte; Lindsay J Hines; Jessica M Foley; Amir Ramezani; Elyse J Singer; Steven A Castellon; Robert K Heaton; Charles H Hinkin
Journal:  Clin Neuropsychol       Date:  2011-02       Impact factor: 3.535

5.  Medication and finance management among HIV-infected adults: the impact of age and cognition.

Authors:  April D Thames; Michelle S Kim; Brian W Becker; Jessica M Foley; Lindsay J Hines; Elyse J Singer; Robert K Heaton; Steven A Castellon; Charles H Hinkin
Journal:  J Clin Exp Neuropsychol       Date:  2010-08-06       Impact factor: 2.475

6.  Cognitive complaints, depressive symptoms, and cognitive impairment: are they related?

Authors:  Timothy J Hohman; Lori L Beason-Held; Susan M Resnick
Journal:  J Am Geriatr Soc       Date:  2011-09-13       Impact factor: 5.562

7.  A comparison of clinician-rated neuropsychological and self-rated cognitive assessments in patients with asthma and rheumatologic disorders.

Authors:  Alan B Frol; Aracely Vasquez; Yonatan Getahun; Maria Pacheco; David A Khan; E Sherwood Brown
Journal:  Allergy Asthma Proc       Date:  2013 Mar-Apr       Impact factor: 2.587

8.  Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study.

Authors:  Martin McElhiney; Judith Rabkin; Wilfred Van Gorp; Richard Rabkin
Journal:  J Clin Exp Neuropsychol       Date:  2009-11-24       Impact factor: 2.475

9.  Memory-based strategies for antiretroviral medication management: an evaluation of clinical predictors, adherence behavior awareness, and effectiveness.

Authors:  K Blackstone; S P Woods; E Weber; I Grant; D J Moore
Journal:  AIDS Behav       Date:  2013-01

10.  [Formula: see text]The Relative Utility of Three English Language Dominance Measures in Predicting the Neuropsychological Performance of HIV+ Bilingual Latino/a Adults.

Authors:  Caitlin Miranda; Miguel Arce Rentería; Armando Fuentes; Kelly Coulehan; Alyssa Arentoft; Desiree Byrd; Ana Rosario; Jennifer Monzones; Susan Morgello; Monica Rivera Mindt
Journal:  Clin Neuropsychol       Date:  2016-03-03       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.